Alnylam Pharmaceuticals

About:

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

Website: http://www.alnylam.com

Twitter/X: Alnylam

Top Investors: Merck, ARCH Venture Partners, Takeda, Regeneron, Polaris Partners

Description:

Alnylam is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.